OpportunityTitle: Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Only currently active NINDS Rare Diseases Consortia are eligible to apply.
Description: The purpose of this limited competition Funding Opportunity Announcement (FOA) is to provide an opportunity for the NINDS American Recovery and Reinvestment Act (ARRA)-funded consortia to compete for another three years of participation in the Rare Diseases Clinical Research Network (RDCRN). The RDCRN is a collaborative and coordinated network of Clinical Research Consortia comprised of investigators and patient support groups committed to investigation of rare diseases working in partnership with the Data Management Coordinating Center to enhance communication and sharing of resources in a multidisciplinary approach. The RDCRN is focused on 1) the collection of clinical information to better define disease natural history and to develop biomarkers as well as new approaches to diagnosis, prevention, and treatment of rare diseases, and 2) training of new clinical investigators in rare diseases research.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;